1st Quarter - Report

ECOLAB INC. for ECOLAB INC

Period 1st Quarter 2026 Filed Apr 20, 2026 Signed by James Bailey

Official filing
Firm
ECOLAB INC.
Client
ECOLAB INC
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

Discussions related to environmental policies and issues including water infrastructure, water reuse, water efficiency, water resource management, and sustainability. Discussions related to energy and water efficiency initiatives. Discussions related to the implementation of the Pesticide Registration Improvement Act, P.L.117-103. Discussions related to data center water efficiency and energy efficiency.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: Executive Office of the President (EOP); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Energy, Dept of; Interior, Dept of (DOI); Environmental Protection Agency (EPA)

Taxation/Internal Revenue Code TAX

Discussions regarding scope of Sec. 48D investment tax credit; Discussions related to corporate taxation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Discussions related to supply chain challenges. Discussions regarding trade policy and tariffs.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); State, Dept of (DOS); Commerce, Dept of (DOC)

Energy/Nuclear ENG

Discussions regarding sustainable aviation fuel. Discussions regarding permitting reform. Discussions regarding Department of Energy programs for critical mineral production, including the use of resins as extraction technology. Discussions regarding optimization of power generation.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: Executive Office of the President (EOP); Energy, Dept of; HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Discussions regarding biopharmaceutical manufacturing policy. Discussions regarding drug manufacturing regulations.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.